Product Data Sheet

SARS-CoV-2-IN-89

Catalog No. A53496

main product photo
SARS-CoV-2-IN-89 is a potent inhibitor targeting SARS-CoV-2. This compound enhances interferon type I (IFN-I) responses in A549.hACE2 cells upon viral infection, making it a valuable tool for studying antiviral mechanisms and developing therapeutic strategies against COVID-19. Its application in research facilitates a deeper understanding of the immune response to SARS-CoV-2.
Chemical Information
Catalog NumA53496
M. Wt280.30
FormulaC17H13FN2O
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.1016762-41-6
Synonyms
SMILESO=C(C1=CC=CC2=C1C=CC=C2)NC3=CC(N)=CC=C3F
Biological Activity
DescriptionSARS-CoV-2-IN-89 is a potent inhibitor targeting SARS-CoV-2. This compound enhances interferon type I (IFN-I) responses in A549.hACE2 cells upon viral infection, making it a valuable tool for studying antiviral mechanisms and developing therapeutic strategies against COVID-19. Its application in research facilitates a deeper understanding of the immune response to SARS-CoV-2.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.